Mpirik’s Cardiac Intelligence® (CI) soware analyzes echocardiogram reports, CT reports, and other diagnostic results to identify patients with characteristics of cardiac disease. Diagnostic results from the electronic health record (EHR) are sent to Mpirik, analyzed by Mpirik’s algorithms, and the results are displayed through Mpirik’s web-based platform. Through the CI platform, clinicians can view their patient population, manage identified patients with the purpose of eliminating undertreatment, and receive automated alert notifications on patients identified with no appropriate follow-up plan. The real-time availability of the platform, data, and alert notifications drives workflow efficiency and saves time on clinicians data review. The primary focus is to help the cardiovascular service lines improve their cardiovascular disease detection, while also tracking patients through the progression of the disease to ensure the right treatment at the right time.

Patients with cardiovascular disease require evidence-based and timely treatment to ensure favorable outcomes. This is critical for delivering the best patient care and for optimizing the healthcare system. The Cardiac Intelligence® platform identifies critical findings, filters extraneous data and facilitates communication to expert clinical team members. Tailored to your organization's needs, Cardiac Intelligence® tracks patients through the progression of the disease and ensures that patients receive proper and timely follow-up. It’s all about the right care at the right time.

Emulate, Inc. is a private company focused on commercializing Organs-on-Chips as an automated human bioemulation platform that achieves a new standard for mimicking true human physiology so that responses to medicines, chemicals and diseases can be accurately predicted. Through co-innovation with collaborators and internal programs, Emulate is advancing product innovation, design and safety across a range of applications in drug development, personalized medicine, agriculture and chemical-based consumer products.

Emulate, Inc. is a private company focused on commercializing Organs-on-Chips as an automated human bioemulation platform that achieves a new standard for mimicking true human physiology so that responses to medicines, chemicals and diseases can be accurately predicted. Through co-innovation with collaborators and internal programs, Emulate is advancing product innovation, design and safety across a range of applications in drug development, personalized medicine, agriculture and chemical-based consumer products.